Gene · 6375
XCL1: X-C motif chemokine ligand 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. XCL1: X-C motif chemokine ligand 1. Genes, record 6375. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6375
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P47992 | Lymphotactin | 114 | 7 | Ensembl, GeneID, HGNC |
Source UniProt
Patents151
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026120675 A | 2026-07-22 | 762 | P47992 | Espacenet |
| EP 4705273 A2 | 2026-03-11 | 247 | P47992 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 40989 | P47992 | Espacenet |
| WO 2025260013 A1 | 2025-12-18 | 8 | P47992 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8304 | P47992 | Espacenet |
| EP 4641203 A2 | 2025-10-29 | 240 | P47992 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 14356 | P47992 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 16794 | P47992 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 8097 | P47992 | Espacenet |
| EP 4608443 A1 | 2025-09-03 | 10 | P47992 | Espacenet |
1 to 10 of 151
See all 151 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,721
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | XCL1 papers | Newest fiscal year |
|---|---|---|---|
| ZIALM202011 | Predictions and experimental validation of fold-switching proteins | 10 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| R37AI058072 | Structural Basis for Chemokine Function | 8 | 2025 |
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 5 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 5 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 5 | 2025 |
| P30CA196521 | The Tisch Cancer Institute - Cancer Center Support Grant | 5 | 2025 |
| U19AI118626 | Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment | 5 | 2025 |
| U19AI128949 | Human anti-viral immune responses in tissues and circulation | 5 | 2025 |
1 to 10 of 1,721Source NIH's project files
See all 1,721 nih grantsPapers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Thermodynamics and Kinetics of Dimerization-Coupled Fold Switching in the Chemokine XCL1. | Proteins | 2026 | 42802474 | PubTator, text mining | PubMed |
| Genetic Regulation of DNA Methylation and Its Mediating Role in Blood Pressure: A Genome-Wide Twin Study. | MedComm (2020) | 2026 | 42756691 | PubTator, text mining | PubMed |
| Assay for Transposase-Accessible Chromatin Sequencing (ATAC-seq) of Cancer Cells in Culture. | Methods Mol Biol | 2026 | 42642593 | PubTator, text mining | PubMed |
| Step-brothers in arms, SAGA and ATAC co-activator complexes, use different strategies. | EMBO J | 2026 | 42581098 | PubTator, text mining | PubMed |
| SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8+ T cell immunity against bulky tumors via an IFN-I/NK/DC axis. | Nat Commun | 2026 | 42420294 | PubTator, text mining | PubMed |
| Long non-coding RNA CARDINAL cis-activates MYOCD expression by recruiting histone reader ZZZ3 in vascular smooth muscle cell phenotype alteration. | Cardiovasc Res | 2026 | 42417424 | PubTator, text mining | PubMed |
| Neutrophil extracellular traps drive local tumor progression and metastasis following thermal ablation in liver cancer via TLR9-mediated inflammatory feedback and immunosuppression. | J Immunother Cancer | 2026 | 42413984 | PubTator, text mining | PubMed |
| PD-L1-targeted OMV priming licenses myeloid co-stimulation and chemokine circuits to potentiate CAR-T therapy in advanced-stage solid tumors. | J Nanobiotechnology | 2026 | 42337606 | PubTator, text mining | PubMed |
| Multi-layered functional genomics prioritizes candidate effectors and regulatory mechanisms of ankylosing spondylitis. | Front Immunol | 2026 | 42305533 | PubTator, text mining | PubMed |
| A ubiquitinated E2-based mRNA vaccine confers complete protection against lethal challenge with classical swine fever virus. | J Virol | 2026 | 42283466 | PubTator, text mining | PubMed |
1 to 10 of 2,385
See all 2,385 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6375
GET https://conductscience.org/api/genes/v1/6375/patents?page=2